 Kristie Hadden
Concepts (203)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Literacy | 21 | 2021 | 132 | 7.420 |
Why?
| | Comprehension | 10 | 2021 | 113 | 3.040 |
Why?
| | Patient Education as Topic | 9 | 2019 | 322 | 2.620 |
Why?
| | Teaching Materials | 6 | 2021 | 31 | 1.820 |
Why?
| | Dysphonia | 2 | 2020 | 20 | 1.290 |
Why?
| | Orthopedics | 3 | 2018 | 53 | 1.150 |
Why?
| | Language | 4 | 2019 | 138 | 1.130 |
Why?
| | Community-Based Participatory Research | 2 | 2017 | 204 | 0.880 |
Why?
| | Reading | 3 | 2019 | 73 | 0.800 |
Why?
| | Rural Health Services | 1 | 2024 | 169 | 0.740 |
Why?
| | Analgesics, Opioid | 2 | 2019 | 591 | 0.740 |
Why?
| | Quality Improvement | 3 | 2018 | 224 | 0.720 |
Why?
| | Orthopedic Procedures | 2 | 2019 | 71 | 0.720 |
Why?
| | Academic Medical Centers | 2 | 2018 | 150 | 0.670 |
Why?
| | Arthroplasty, Replacement, Hip | 4 | 2018 | 266 | 0.670 |
Why?
| | Botulinum Toxins, Type A | 1 | 2020 | 14 | 0.670 |
Why?
| | Universal Precautions | 1 | 2019 | 2 | 0.660 |
Why?
| | Voice Training | 1 | 2019 | 11 | 0.650 |
Why?
| | Patients | 1 | 2019 | 51 | 0.630 |
Why?
| | Decision Support Techniques | 1 | 2019 | 71 | 0.620 |
Why?
| | Scoliosis | 1 | 2020 | 62 | 0.620 |
Why?
| | Employment | 1 | 2019 | 93 | 0.620 |
Why?
| | Rural Population | 3 | 2024 | 572 | 0.590 |
Why?
| | Diabetic Foot | 1 | 2019 | 76 | 0.590 |
Why?
| | Multilingualism | 1 | 2018 | 8 | 0.580 |
Why?
| | Organizational Culture | 1 | 2018 | 44 | 0.570 |
Why?
| | Education, Nonprofessional | 1 | 2017 | 8 | 0.570 |
Why?
| | Human Experimentation | 1 | 2017 | 11 | 0.570 |
Why?
| | Humans | 33 | 2024 | 52593 | 0.570 |
Why?
| | Social Support | 1 | 2019 | 268 | 0.560 |
Why?
| | Arthroplasty, Replacement, Knee | 3 | 2018 | 289 | 0.560 |
Why?
| | Telemedicine | 1 | 2024 | 493 | 0.550 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 358 | 0.550 |
Why?
| | Self Care | 1 | 2018 | 138 | 0.550 |
Why?
| | Research Subjects | 1 | 2017 | 53 | 0.540 |
Why?
| | Preoperative Care | 1 | 2018 | 174 | 0.530 |
Why?
| | Patient-Centered Care | 1 | 2018 | 140 | 0.530 |
Why?
| | Prisoners | 1 | 2018 | 98 | 0.520 |
Why?
| | Mass Screening | 1 | 2019 | 358 | 0.520 |
Why?
| | Hand | 1 | 2016 | 51 | 0.500 |
Why?
| | Caregivers | 1 | 2018 | 238 | 0.490 |
Why?
| | Students | 2 | 2015 | 228 | 0.480 |
Why?
| | Health Occupations | 1 | 2015 | 19 | 0.470 |
Why?
| | Religion and Medicine | 1 | 2015 | 20 | 0.460 |
Why?
| | Physicians | 1 | 2018 | 241 | 0.450 |
Why?
| | Health Knowledge, Attitudes, Practice | 4 | 2021 | 510 | 0.430 |
Why?
| | Biomedical Research | 1 | 2017 | 258 | 0.420 |
Why?
| | Arkansas | 5 | 2024 | 2029 | 0.410 |
Why?
| | Speech-Language Pathology | 1 | 2013 | 18 | 0.410 |
Why?
| | Audiology | 1 | 2013 | 19 | 0.400 |
Why?
| | Stress, Psychological | 1 | 2015 | 273 | 0.390 |
Why?
| | Health Promotion | 1 | 2015 | 268 | 0.380 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 567 | 0.380 |
Why?
| | Cross-Sectional Studies | 3 | 2020 | 1686 | 0.310 |
Why?
| | Communication | 2 | 2020 | 257 | 0.270 |
Why?
| | Health Education | 2 | 2021 | 156 | 0.270 |
Why?
| | Internet | 3 | 2021 | 262 | 0.260 |
Why?
| | Female | 15 | 2022 | 28262 | 0.240 |
Why?
| | Quality of Life | 3 | 2020 | 882 | 0.240 |
Why?
| | Patient Readmission | 2 | 2016 | 246 | 0.220 |
Why?
| | Hospitals, Rural | 1 | 2024 | 25 | 0.210 |
Why?
| | Rural Health | 1 | 2024 | 88 | 0.210 |
Why?
| | Male | 12 | 2021 | 26863 | 0.210 |
Why?
| | Educational Measurement | 2 | 2015 | 198 | 0.210 |
Why?
| | United States | 4 | 2019 | 5227 | 0.190 |
Why?
| | Focus Groups | 3 | 2022 | 197 | 0.180 |
Why?
| | Adult | 9 | 2021 | 14170 | 0.180 |
Why?
| | Delivery of Health Care | 1 | 2024 | 324 | 0.180 |
Why?
| | Guidelines as Topic | 2 | 2019 | 110 | 0.180 |
Why?
| | Pregnancy in Adolescence | 1 | 2020 | 11 | 0.170 |
Why?
| | Middle Aged | 8 | 2021 | 13096 | 0.170 |
Why?
| | Muscle Tonus | 1 | 2019 | 22 | 0.160 |
Why?
| | Social Media | 1 | 2022 | 117 | 0.160 |
Why?
| | Voice Quality | 1 | 2019 | 33 | 0.160 |
Why?
| | Chest Pain | 1 | 2019 | 58 | 0.160 |
Why?
| | Behavior Therapy | 2 | 2018 | 179 | 0.160 |
Why?
| | Personal Satisfaction | 1 | 2019 | 75 | 0.160 |
Why?
| | Urology | 1 | 2019 | 19 | 0.150 |
Why?
| | Societies, Medical | 2 | 2019 | 202 | 0.150 |
Why?
| | Pelvic Floor Disorders | 1 | 2019 | 29 | 0.150 |
Why?
| | Puerto Rico | 1 | 2018 | 17 | 0.150 |
Why?
| | Adaptation, Psychological | 1 | 2020 | 229 | 0.150 |
Why?
| | Age Factors | 2 | 2021 | 1132 | 0.150 |
Why?
| | Goals | 1 | 2018 | 44 | 0.150 |
Why?
| | Retrospective Studies | 4 | 2019 | 6671 | 0.150 |
Why?
| | Gynecology | 1 | 2019 | 52 | 0.150 |
Why?
| | Inservice Training | 1 | 2018 | 30 | 0.140 |
Why?
| | Attitude | 1 | 2018 | 70 | 0.140 |
Why?
| | Ethics, Research | 1 | 2017 | 39 | 0.140 |
Why?
| | Self Efficacy | 1 | 2018 | 135 | 0.140 |
Why?
| | Recovery of Function | 1 | 2018 | 202 | 0.140 |
Why?
| | Health Services Research | 1 | 2018 | 153 | 0.140 |
Why?
| | Pain | 1 | 2020 | 362 | 0.140 |
Why?
| | Pilot Projects | 2 | 2021 | 721 | 0.130 |
Why?
| | Parents | 1 | 2020 | 332 | 0.130 |
Why?
| | Residence Characteristics | 1 | 2017 | 160 | 0.130 |
Why?
| | Patient Navigation | 1 | 2016 | 13 | 0.130 |
Why?
| | Patient Satisfaction | 1 | 2018 | 284 | 0.130 |
Why?
| | Aged | 7 | 2021 | 10191 | 0.130 |
Why?
| | Medicine | 1 | 2017 | 53 | 0.130 |
Why?
| | Consumer Health Information | 1 | 2016 | 19 | 0.130 |
Why?
| | Critical Pathways | 1 | 2016 | 36 | 0.130 |
Why?
| | Arthroplasty, Replacement | 1 | 2016 | 27 | 0.120 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2015 | 1 | 0.120 |
Why?
| | Disease Transmission, Infectious | 1 | 2015 | 12 | 0.120 |
Why?
| | Immunization Schedule | 1 | 2015 | 11 | 0.120 |
Why?
| | Whooping Cough | 1 | 2015 | 11 | 0.120 |
Why?
| | Sex Factors | 1 | 2018 | 729 | 0.120 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 606 | 0.120 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 524 | 0.120 |
Why?
| | Ambulatory Care Facilities | 1 | 2016 | 124 | 0.120 |
Why?
| | Hospitalization | 1 | 2019 | 749 | 0.110 |
Why?
| | Medication Adherence | 1 | 2016 | 133 | 0.110 |
Why?
| | Advisory Committees | 1 | 2015 | 71 | 0.110 |
Why?
| | Writing | 1 | 2015 | 45 | 0.110 |
Why?
| | Pain Management | 1 | 2015 | 179 | 0.100 |
Why?
| | Program Evaluation | 1 | 2015 | 353 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2015 | 228 | 0.100 |
Why?
| | Length of Stay | 1 | 2016 | 674 | 0.100 |
Why?
| | Needs Assessment | 1 | 2013 | 139 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2015 | 216 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1205 | 0.090 |
Why?
| | Data Collection | 1 | 2013 | 289 | 0.090 |
Why?
| | Cohort Studies | 1 | 2016 | 1553 | 0.090 |
Why?
| | Neoplasms | 1 | 2021 | 1308 | 0.090 |
Why?
| | Curriculum | 1 | 2013 | 399 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2018 | 5486 | 0.070 |
Why?
| | Young Adult | 3 | 2021 | 4337 | 0.060 |
Why?
| | Smog | 1 | 2021 | 5 | 0.040 |
Why?
| | Videotape Recording | 1 | 2021 | 27 | 0.040 |
Why?
| | Pregnancy | 2 | 2020 | 2679 | 0.040 |
Why?
| | Patient Selection | 1 | 2022 | 266 | 0.040 |
Why?
| | Aged, 80 and over | 2 | 2019 | 3420 | 0.040 |
Why?
| | Adolescent | 3 | 2021 | 6737 | 0.040 |
Why?
| | Pamphlets | 1 | 2019 | 8 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2021 | 403 | 0.040 |
Why?
| | Health Behavior | 1 | 2021 | 257 | 0.040 |
Why?
| | Pandemics | 1 | 2022 | 587 | 0.030 |
Why?
| | Postoperative Period | 1 | 2016 | 172 | 0.030 |
Why?
| | Reminder Systems | 1 | 2016 | 28 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2016 | 96 | 0.030 |
Why?
| | Medication Therapy Management | 1 | 2016 | 22 | 0.030 |
Why?
| | Digitoxin | 1 | 1975 | 4 | 0.030 |
Why?
| | Health Expenditures | 1 | 2016 | 74 | 0.030 |
Why?
| | Naphthalenesulfonates | 1 | 1975 | 2 | 0.030 |
Why?
| | Azo Compounds | 1 | 1975 | 11 | 0.030 |
Why?
| | Odds Ratio | 1 | 2016 | 568 | 0.030 |
Why?
| | Random Allocation | 1 | 2015 | 287 | 0.030 |
Why?
| | Microsomes, Liver | 1 | 1975 | 185 | 0.030 |
Why?
| | Antibodies | 1 | 1975 | 150 | 0.030 |
Why?
| | Comorbidity | 1 | 2016 | 631 | 0.030 |
Why?
| | Reoperation | 1 | 2016 | 465 | 0.030 |
Why?
| | Logistic Models | 1 | 2016 | 934 | 0.030 |
Why?
| | Health Personnel | 1 | 2016 | 252 | 0.030 |
Why?
| | Ligaments, Articular | 1 | 1980 | 8 | 0.020 |
Why?
| | Knee Injuries | 1 | 1980 | 28 | 0.020 |
Why?
| | Prospective Studies | 1 | 2015 | 2457 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2016 | 1081 | 0.020 |
Why?
| | Risk Factors | 1 | 2016 | 3952 | 0.020 |
Why?
| | Pepsin A | 1 | 1975 | 2 | 0.020 |
Why?
| | Parotid Gland | 1 | 1975 | 10 | 0.020 |
Why?
| | Isoproterenol | 1 | 1975 | 56 | 0.020 |
Why?
| | Platelet Aggregation | 1 | 1975 | 78 | 0.010 |
Why?
| | Cyclic AMP | 1 | 1975 | 92 | 0.010 |
Why?
| | Epinephrine | 1 | 1975 | 93 | 0.010 |
Why?
| | Sesquiterpenes | 1 | 1975 | 92 | 0.010 |
Why?
| | Blood Platelets | 1 | 1975 | 263 | 0.010 |
Why?
| | DNA | 1 | 1975 | 549 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 2 | 1975 | 180 | 0.010 |
Why?
| | Rabbits | 2 | 1975 | 373 | 0.010 |
Why?
| | Animals | 4 | 1975 | 13507 | 0.010 |
Why?
| | Digitoxigenin | 1 | 1975 | 5 | 0.010 |
Why?
| | Chromatography, Thin Layer | 1 | 1975 | 23 | 0.010 |
Why?
| | NADP | 1 | 1975 | 23 | 0.010 |
Why?
| | Hydroxylation | 1 | 1975 | 65 | 0.010 |
Why?
| | Isoelectric Focusing | 1 | 1975 | 8 | 0.010 |
Why?
| | Anilino Naphthalenesulfonates | 1 | 1975 | 5 | 0.010 |
Why?
| | Binding Sites, Antibody | 1 | 1975 | 15 | 0.010 |
Why?
| | Chromatography, Ion Exchange | 1 | 1975 | 15 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 1975 | 46 | 0.010 |
Why?
| | Kinetics | 1 | 1975 | 622 | 0.010 |
Why?
| | Protein Binding | 1 | 1975 | 673 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 2 | 1975 | 1378 | 0.010 |
Why?
| | Movement | 1 | 1980 | 81 | 0.000 |
Why?
| | Rats | 1 | 1975 | 3203 | 0.000 |
Why?
| | Time Factors | 1 | 1975 | 3000 | 0.000 |
Why?
| | Radiography | 1 | 1980 | 474 | 0.000 |
Why?
| | Knee Joint | 1 | 1980 | 165 | 0.000 |
Why?
| | Dihydroergotamine | 1 | 1975 | 5 | 0.000 |
Why?
| | Lysergic Acid Diethylamide | 1 | 1975 | 6 | 0.000 |
Why?
| | Radiation Effects | 1 | 1975 | 4 | 0.000 |
Why?
| | Trichloroacetic Acid | 1 | 1975 | 8 | 0.000 |
Why?
| | Cycloheximide | 1 | 1975 | 34 | 0.000 |
Why?
| | Methods | 1 | 1975 | 53 | 0.000 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1975 | 34 | 0.000 |
Why?
| | Dactinomycin | 1 | 1975 | 23 | 0.000 |
Why?
| | X-Rays | 1 | 1975 | 55 | 0.000 |
Why?
| | Tyrosine | 1 | 1975 | 91 | 0.000 |
Why?
| | Plants, Medicinal | 1 | 1975 | 35 | 0.000 |
Why?
| | Mice, Inbred Strains | 1 | 1975 | 164 | 0.000 |
Why?
| | Drug Interactions | 1 | 1975 | 205 | 0.000 |
Why?
| | Hemoglobins | 1 | 1975 | 111 | 0.000 |
Why?
| | Mice | 1 | 1975 | 5958 | 0.000 |
Why?
|
|
Hadden's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|